Initiated two late-stage clinical trials of LB-102: the pivotal Phase 3 NOVA-2 trial in schizophrenia and the Phase 2 ILLUMINATE-1 trial in ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

A randomized trial published in the American Journal of Psychiatry has found that magnetic seizure therapy (MST) achieved ...

Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in-depth exploration of how esketamine therapy is being used to manage ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Trisha Suppes, MD, ...

Developing Therapeutics for the Treatment of CNS Disorders, Specifically Suicidal Bipolar Depression, Chronic Pain and PTSD. Received $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus ...

Imagine wading through severe depression for years, taking medication after medication, with no relief. Now, envision discovering that what you were facing was not major depression but bipolar ...

A meta-analysis of 26 trials found that IV ketamine rapidly reduced suicidal and depressive symptoms in patients with major ...